N-(Azido-PEG3)-N-Boc-PEG3-NHS ester

 CAS No.: 2112731-51-6  Cat No.: BP-500449  Purity: 98% 4.5  

N-(Azido-PEG3)-N-Boc-PEG3-NHS ester is a heterobifunctional, PEG-based PROTAC linker featuring an NHS-activated ester for amide coupling and a terminal azide handle for orthogonal bioorthogonal conjugation. Structurally, it contains two short PEG3 segments that provide aqueous solubility, conformational flexibility, and a defined spacer length between the reactive ends, while the Boc-protected amine enables controlled functionalization and can be deprotected under standard conditions when required for subsequent coupling steps. In PROTAC design, the NHS ester allows efficient attachment to primary amines on a ligand, targeting moiety, or intermediate scaffold, forming a stable amide bond, whereas the azide group can be used for strain-promoted or copper-catalyzed azide–alkyne cycloaddition to install a complementary partner. This combination supports modular assembly of targeted protein degraders, improves linker tunability, and facilitates systematic structure–activity studies by enabling rapid, orthogonal conjugation workflows.

N-(Azido-PEG3)-N-Boc-PEG3-NHS ester

Structure of 2112731-51-6

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
PROTAC Linker
Molecular Formula
C₂₆H₄₅N₅O₁₂
Molecular Weight
619.66

* For research and manufacturing use only. Not for human or clinical use.

SizePriceStockQuantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

  • Comprehensive PROTAC Platform
  • Scientific Expertise & Technical Support
  • Custom Synthesis & Design Service
  • Extensive Product Coverage
  • Cutting-Edge Innovation
  • Fast Delivery & Global Support
  • 24/7 customer service
  • 100% quality assurance
Popular Publications Citing BOC Sciences Products
Purity
98%
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Shipping
Room temperature in continental US; may vary elsewhere.
IUPACName
(2,5-dioxopyrrolidin-1-yl) 3-[2-[2-[2-[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]ethoxy]ethoxy]ethoxy]propanoate
Synonyms
2,5-dioxopyrrolidin-1-yl 3-(2-{2-[2-(16-azido-2,2-dimethyl-4-oxo-3,8,11,14-tetraoxa-5-azahexadecan-5-yl)ethoxy]ethoxy}ethoxy)propanoate
InChI Key
KGZHKOJBRRUXFU-UHFFFAOYSA-N
InChI
InChI=1S/C26H45N5O12/c1-26(2,3)42-25(35)30(9-13-39-17-21-41-19-15-37-11-7-28-29-27)8-12-38-16-20-40-18-14-36-10-6-24(34)43-31-22(32)4-5-23(31)33/h4-21H2,1-3H3
SMILES
CC(C)(C)OC(=O)N(CCOCCOCCOCCC(=O)ON1C(=O)CCC1=O)CCOCCOCCOCCN=[N+]=[N-]
1. Establishment of a 1, 4, 7, 10-tetraazacyclododecane-1,4,7,10-tetraacetic acid mono-N-hydroxysuccinimide ester (DOTA-NHS-ester) based lectin microarray for efficiently detecting serum glycans in gastric cancers
Yi Gao, Song-Guo Li, Qian Liu, Sheng-Sheng Liu, Lei Ye, Zi-Jian Song, Wei-Dong Du Anal Biochem. 2020 May 15;597:113686.doi: 10.1016/j.ab.2020.113686.Epub 2020 Mar 7.
Development of cancers is involved in changes of a variety of glycans. Lectin microarray is one of the most powerful methodologies for investigation of glycan alterations in biological samples with its advantages of high through-put, selectivity and specificity of the technique. However, utilization of lectin microarrays available commercially keeps of great challenges. In this study, we took use of the molecular self-assembled monolayer technique to modify a gold surface with the reagent 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid mono-N-hydroxysuccinimide ester (DOTA-NHS-ester) in combination with 16-amino-1-hexadecanethiol hydrochloride. Cross-linking effect of DOTA-NHS-ester is brought about via activating three -OH ends to three terminals of succinylimidines, making selective binding of the terminal amino groups in proteins possible. We immobilized ten commercial lectins on the platform and measured changes of serum lectin-matched glycans in patients with gastric cancer. The results demonstrated that this biochip modification platform conferred impressive chemical surface stabilization, sensitivity and geometric images. We observed that all the serum glycans tested in the patients were significantly higher than those in the controls (P < 0.05). The biochip would provide a versatile platform for investigation of potential glycan biomarkers in making tumor diagnosis decision and analyzing escape of tumors from immunity.

This N-(Azido-PEG3)-N-Boc-PEG3-NHS ester is a bifunctional PEG-based linker designed for modular PROTAC assembly, combining an NHS-activated ester for efficient conjugation and a terminal azide handle for orthogonal click chemistry. Its PEG segments provide conformational flexibility and improved solubility, supporting productive formation of ternary complexes. The azide enables site-specific attachment to complementary partners under mild conditions, while the protected amine functionality facilitates controlled downstream coupling. Detailed structural and reactivity considerations are provided below.

Structure: The linker contains PEG oligomer segments connected through ether linkages, providing hydrophilicity and chain flexibility. An NHS-activated carboxylate enables acyl transfer to nucleophiles, while an azide provides a bioorthogonal functional group for cycloaddition. A Boc-protected amine supports orthogonal reactivity and controlled deprotection prior to further coupling.

Reactivity: The NHS ester reacts with primary amines or other suitable nucleophiles to form stable amide bonds, typically using an amine-containing acceptor in mildly basic aqueous or mixed solvent systems. The azide is compatible with copper-free or copper-catalyzed azide–alkyne cycloaddition, depending on the partner and desired selectivity. Boc groups are removed under standard acidolysis conditions when subsequent amide or urea-forming steps are required; catalysts and solvents are chosen to preserve the NHS functionality until coupling is complete.

Stock concentration: *
Desired final volume: *
Desired concentration: *

L

* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2

* Total Molecular Weight:
g/mol
Tip: Chemical formula is case sensitive. C22H30N4O c22h30n40
g/mol
g

Related Product Recommendations

BOC Sciences Support

Please contact us with any specific requirements and we will get back to you as soon as possible.


  • Verification code
Inquiry Basket